Christopher W. Krueger, Chief Business Officer at Ventyx Biosciences, Inc. (VTYX), sold 29,977 shares at $32.25 ($977K) on 2023-09-05, disclosed to the SEC on 2023-09-07.
Open-market sale of $977k VTYX by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.25 | 10,431 | $336K | 34.4% |
| 2 | $32.25 | 10,431 | $336K | 34.4% |
| 3 | $33.42 | 4,546 | $152K | 15.5% |
| 4 | $33.42 | 4,546 | $152K | 15.5% |
| 5 | $33.97 | 23 | $781 | 0.1% |
| Total | $32.61 avg | 29,977 |
| $977K |
| 100% |
| Filing → |
| VTYX | SELL | 2023-10-04 | $869K | — | Filing → |
| VTYX | SELL | 2023-08-04 | $1.1M | — | Filing → |
| VTYX | SELL | 2023-07-05 | $1.1M | — | Filing → |